Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
PR
PERRIGO COMPANY PLC
PRGO
Mkt Cap
$2.31B
Volume
2.11M
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
PR
PRGO
PR
PERRIGO COMPANY PLC
PRGO
News
·
This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.
Mkt Cap
$2.31B
Volume
2.11M
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.
Perrigo, a generic over-the-counter drug manufacturer, offers an attractive 8.3% dividend yield, but the article warns investors to be cautious. The company faces declining sales (down 3.1% YoY), weakening margins, and leadership uncertainty following the CEO's abrupt departure. While the dividend appears covered for now, risks include a shrinking business, potential asset sales, and the possibility of dividend cuts under new management.
The Motley Fool · Aug 22, 2026
Perrigo Announces Quarterly Dividend
Perrigo Company plc announced that its Board of Directors has approved a quarterly dividend of $0.29 per share ($1.16 annualized). The dividend is payable on June 16, 2026, to shareholders of record on May 29, 2026.
Benzinga · Apr 29, 2026
3 Healthcare Stocks Paying the Highest Dividends in the Sector Right Now
The article examines three high-yielding healthcare stocks: Perrigo (9.6% yield) faces growth slowdown and profitability pressure despite a 23-year dividend streak; Healthpeak Properties (7.1% yield) offers potential upside through its Janus Living spinoff; Medical Properties Trust (6.8% yield) has stabilized after significant dividend cuts due to tenant bankruptcies but faces ongoing debt maturities.
The Motley Fool · Apr 29, 2026
5 Small Stocks, 5 Super-Sized Payouts of Up To 11%
The article highlights five small-cap stocks offering high dividend yields (6.6%-11%) that remain undervalued despite strong 2026 performance. The author recommends regional banks and energy companies as income-generating opportunities, though warns of risks including economic sensitivity and potential dividend sustainability concerns.
Investing.com · Mar 6, 2026
Good Start® | Dr. Brown's™ Infant Formulas Receive “Baby Food Product of the Year” In Fifth Annual Baby Innovation Awards
Good Start® | Dr. Brown's™ infant formula has been named 'Baby Food Product of the Year' at the 2025 Baby Innovation Awards. The partnership combines Good Start's 50+ year heritage with Dr. Brown's pediatrician-recommended bottles to offer tolerance-focused infant formulas including Soothe Pro®, Gentle Pro®, and Soy-ease Pro® variants designed to address common feeding challenges like fussiness, gas, and digestive issues.
GlobeNewswire Inc. · Mar 3, 2026
Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally
The global scar treatment market is projected to grow from USD 26.60 billion in 2025 to USD 56.30 billion by 2033, with a CAGR of 9.91%. Growth is driven by increasing awareness of advanced cosmetic and reconstructive procedures, rising prevalence of acne, surgical, and traumatic scars, and technological advancements in minimally invasive treatments. The U.S. market alone is expected to reach USD 17.69 billion by 2033.
GlobeNewswire Inc. · Feb 18, 2026
3 Healthcare Stocks Paying the Highest Dividends of 2026
The article examines three high-yielding healthcare stocks: Perrigo (8.2% yield) is cautioned as a potential value trap despite strong dividend history; Pfizer (6.7% yield) is viewed more favorably with post-COVID catalysts and GLP-1 product launches; Embecta (5.5% yield) shows turnaround potential as it pivots toward the GLP-1 pen needle business.
The Motley Fool · Feb 6, 2026
Infant Nutrition Market Projected to Reach US$ 162.08 Billion by 2035, Supported by Regulatory Developments and Product Innovation Says Astute Analytica
The global infant nutrition market is shifting from volume-based to value-driven growth, projected to reach $162.08 billion by 2035 at a 10.26% CAGR. Despite declining birth rates, premium formulations and specialized nutrition products are driving growth. Major players are investing heavily in domestic manufacturing, regulatory compliance, and product innovation, while safety recalls and consolidation reshape the competitive landscape.
GlobeNewswire Inc. · Feb 2, 2026
Perrigo Celebrates National Store Brand Month by Spotlighting Smarter Over-the-Counter Health and Self-Care Choices
Perrigo Company PLC is highlighting National Store Brand Month, emphasizing how store brand over-the-counter (OTC) health and self-care products offer consumers 25%-30% retail price savings compared to national name brands while maintaining the same active ingredients and FDA standards. The company encourages consumers to stock up on essential OTC products like pain relievers, cough suppressants, and decongestants as cold and flu season peaks.
Benzinga · Jan 21, 2026
Bronstein, Gewirtz & Grossman LLC Urges Perrigo Company plc Investors to Act: Class Action Filed Alleging Investor Harm
A class action lawsuit has been filed against Perrigo Company plc alleging that the company made materially false statements and failed to disclose significant issues with its infant formula business acquired from Nestlé, including underinvestment, manufacturing deficiencies, and overstated financial results. Investors who purchased Perrigo securities between February 27, 2025 and November 4, 2025 are encouraged to join the case.
GlobeNewswire Inc. · Jan 16, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
PR
PRGO
PERRIGO COMPANY PLC
Buy
Sell
Market
Limit
Soon
PRGO
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any PRGO yet.
Related Tickers
Earnings
Dividends
Last · Aug 28
Quarterly
Amount
$0.29
Yield
6.98%
Annual
$1.16